Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate

other OA: closed public-domain-us
View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-07-17

Prolonged goserelin acetate treatment maintained normal AMH levels but profoundly suppressed LH, suggesting the need for exogenous LH or GnRH agonist administration for IVF.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The size of the pool of growing follicles was normal after prolonged down-regulation, as indicated by normal AMH levels 4 and 8 weeks after goserelin administration. However, there was a profound down-regulation of LH levels; therefore we suggest administration of exogenous LH to proceed to IVF or alternatively stimulation of endogenous LH secretion with daily administration of GnRH agonist. These need to be assessed prospectively.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Follicle Stimulating Hormone Glycoproteins Goserelin Luteinizing Hormone Pituitary Gland Testicular Hormones Anti-Mullerian Hormone Down-Regulation Down-Regulation Endometriosis Female Follicle Stimulating Hormone Glycoproteins Goserelin Humans Luteinizing Hormone Pilot Projects Pituitary Gland

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-13T09:25:22.628771+00:00
pubmed
last seen: 2026-05-13T22:15:12.369988+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine